Vis, Daniel J.
Palit, Sander A. L.
Corradi, Marie
Cuppen, Edwin
Mehra, Niven
Lolkema, Martijn P.
Wessels, Lodewyk F. A.
van der Heijden, Michiel S.
Zwart, Wilbert
Bergman, Andries M.
Article History
Received: 17 May 2024
Accepted: 17 February 2025
First Online: 20 March 2025
Declarations
:
: Patients with metastatic disease, including prostate cancer, were included in the CPCT-02 (NCT01855477) metastatic site biopsy study, which was approved by the Medical Ethical Committee of the University Medical Center Utrecht, the Netherlands and was conducted following the Declaration of Helsinki. All patients explicitly consented to WGS and data sharing for cancer research purposes. WGS and clinical data, including primary tumor type and biopsy location, were collected in electronic case record forms and stored in a central database by Hartwig.
: Not applicable.
: None of the authors declared any competing interests.